{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:26:08Z","timestamp":1786980368403,"version":"build-2736575974"},"reference-count":40,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Liver Journal"],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>We describe the association between cirrhosis and outcomes among patients treated for non-small cell lung cancer (NSCLC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>NSCLC cases in 2007\u20132017 in Ontario, Canada, were reviewed. Cirrhosis was identified using validated coding. The association between cirrhosis and outcomes was evaluated using logistic regression, Kaplan\u2013Meier curves, and adjusted survival models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among patients with stage 1\u20133 NSCLC receiving lung resection (n = 59,226), 3% had cirrhosis with higher 30-day (5% versus 2%,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001) and 90-day (8% versus 3%,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001) mortality. After multivariable logistic regression, cirrhosis was associated with higher mortality odds at 30 days (OR 2.35, 95% CI 1.39\u20133.99,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001) and 90 days (OR 2.10, 95% CI 1.38\u20133.21,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001); higher 90-day post-operative complications odds (OR 1.44, 95% CI 1.14\u20131.81,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.002); and higher hospital readmission odds at 30 days (OR 1.90, 95% CI 1.41\u20132.56,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001) and 90 days (OR 1.63, 95% CI 1.27\u20132.10,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.001). Among those with stage 4 NSCLC (n = 27,357), adjusted Cox regression showed cirrhosis was associated with higher mortality (HR 1.10, 95% CI 1.02\u20131.18,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.016). However, when liver-related mortality was a competing event, association between cirrhosis and cancer-specific mortality was absent (sHR 1.04, 95% CI 0.95\u20131.13,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.395). A lower proportion of patients with cirrhosis received systemic treatments (31% versus 40%,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001), and a greater proportion experienced post-treatment complications: electrolyte disturbances (10% versus 5%,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001), kidney injury (5% versus 2%,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.012), and thrombocytopenia (7% versus 2%,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Cirrhosis is associated with increased morbidity and mortality in stage 1\u20133 NSCLC patients undergoing curative surgery. Stage 4 NSCLC patients with cirrhosis are less likely to receive palliative treatment and may experience more post-treatment complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3138\/canlivj-2025-0055","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:59:36Z","timestamp":1784732376000},"page":"450-463","source":"Crossref","is-referenced-by-count":0,"title":["The association between cirrhosis and outcomes among patients with lung cancer in Ontario between 2007 and 2017: A population-based study"],"prefix":"10.3138","volume":"9","author":[{"given":"Adrienne K","family":"Ho","sequence":"first","affiliation":[{"name":"Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Djerboua","sequence":"additional","affiliation":[{"name":"ICES Queen's, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiley","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Surgery, Queen's University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Oncology, Queen's University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9911-0925","authenticated-orcid":true,"given":"Jennifer A","family":"Flemming","sequence":"additional","affiliation":[{"name":"Department of Medicine, Queen's University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1696","reference":[{"key":"e_1_3_11_2_2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi H","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, . Global burden of liver disease: 2023 update. J Hepatol. 2023;79:516\u201337. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.017. Medline: 36990226","journal-title":"J Hepatol"},{"key":"e_1_3_11_3_2","doi-asserted-by":"publisher","DOI":"10.3138\/canlivj-2022-0041"},{"key":"e_1_3_11_4_2","volume-title":"Deaths and mortality rate (age standardization using 2011 population), by selected grouped causes","author":"Statistics Canada","unstructured":"Statistics Canada. Deaths and mortality rate (age standardization using 2011 population), by selected grouped causes. 27 Nov 2023. https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1310080001&pickMembers%5B0%5D=1.1&pickMembers%5B1%5D=2.1&pickMembers%5B2%5D=4.2&cubeTimeFrame.startYear=2010&cubeTimeFrame.endYear=2022&referencePeriods=20100101%2C20220101 (Accessed June 12, 2026)."},{"key":"e_1_3_11_5_2","volume-title":"Lung cancer","author":"WorldHealth Organization","unstructured":"WorldHealth Organization. Lung cancer. 26 Jun 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/lung-cancer (Accessed June 16, 2026)."},{"key":"e_1_3_11_6_2","doi-asserted-by":"crossref","first-page":"e0201120","DOI":"10.1371\/journal.pone.0201120","article-title":"Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: a validation study","volume":"13","author":"Lapointe-Shaaw L","year":"2018","unstructured":"Lapointe-Shaaw L, Georgie F, Carlone D, . Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: a validation study. PLoS One. 2018;13:e0201120. https:\/\/doi.org\/10.1371\/journal.pone.0201120. Medline: 30133446","journal-title":"PLoS One"},{"key":"e_1_3_11_7_2","doi-asserted-by":"crossref","first-page":"e0229218","DOI":"10.1371\/journal.pone.0229218","article-title":"Validation of a hierarchical algorithm to define chronic liver disease and cirrhosis aetiology in administrative healthcare data","volume":"15","author":"Philip G","year":"2020","unstructured":"Philip G, Djerboua M, Carlone D, . Validation of a hierarchical algorithm to define chronic liver disease and cirrhosis aetiology in administrative healthcare data. PLoS One. 2020;15:e0229218. https:\/\/doi.org\/10.1371\/journal.pone.0229218. Medline: 32069337","journal-title":"PLoS One"},{"key":"e_1_3_11_8_2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.24095\/hpcdp.33.3.06","article-title":"Identifying cases of congestive heart failure from administrative data: a validation study using primary care patient records","volume":"33","author":"Schultz S","year":"2013","unstructured":"Schultz S, Rothwell DM, Chen Z, Tu K. Identifying cases of congestive heart failure from administrative data: a validation study using primary care patient records. Chronic Dis Injuries Can. 2013;33:160\u20136. https:\/\/doi.org\/10.24095\/hpcdp.33.3.06. Medline: 23735455","journal-title":"Chronic Dis Injuries Can"},{"key":"e_1_3_11_9_2","first-page":"e18","article-title":"Accuracy of administrative databases in identifying patients with hypertension","volume":"14","author":"Tu K","year":"2007","unstructured":"Tu K, Campbell NR, Chen Z, . Accuracy of administrative databases in identifying patients with hypertension. Open Med. 2007;14:e18\u201326. Medline: 20101286","journal-title":"Open Med"},{"key":"e_1_3_11_10_2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/15412550903140865","article-title":"Identifying individuals with physician diagnosed COPD in health administrative databases","volume":"6","author":"Gershon AS","year":"2009","unstructured":"Gershon AS, Wang C, Guan J, . Identifying individuals with physician diagnosed COPD in health administrative databases. COPD. 2009;6:388\u201394. https:\/\/doi.org\/10.1080\/15412550903140865. Medline: 19863368","journal-title":"COPD"},{"key":"e_1_3_11_11_2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2337\/diacare.25.3.512","article-title":"Diabetes in Ontario","volume":"25","author":"Hux JE","year":"2002","unstructured":"Hux JE, Ivis FJ, Flintoft V, Bica A. Diabetes in Ontario. Diabetes Care. 2002;25:512\u20136. https:\/\/doi.org\/10.2337\/diacare.25.3.512. Medline: 11874939","journal-title":"Diabetes Care"},{"key":"e_1_3_11_12_2","doi-asserted-by":"crossref","first-page":"e21748","DOI":"10.1371\/journal.pone.0021748","article-title":"Validation of case-finding algorithms derived from administrative data for identifying adults living with human immunodeficiency virus infection","volume":"6","author":"Antoniou T","year":"2011","unstructured":"Antoniou T, Zagorski B, Loutfy M, . Validation of case-finding algorithms derived from administrative data for identifying adults living with human immunodeficiency virus infection. PLoS One. 2011;6:e21748. https:\/\/doi.org\/10.1371\/journal.pone.0021748. Medline: 21738786","journal-title":"PLoS One"},{"key":"e_1_3_11_13_2","first-page":"337349","article-title":"Identification of physician-diagnosed Alzheimer's disease and related dementias in population-based administrative data: a validation study using family physicians\u2019 electronic medical records","volume":"54","author":"Jaakkimainen RL","year":"2016","unstructured":"Jaakkimainen RL, Bronskill SE, Tierney MC, . Identification of physician-diagnosed Alzheimer's disease and related dementias in population-based administrative data: a validation study using family physicians\u2019 electronic medical records. J Alzheimer's Dis. 2016;54:337349. https:\/\/doi.org\/10.3233\/JAD-160105. Medline: 27567819","journal-title":"J Alzheimer's Dis"},{"key":"e_1_3_11_14_2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/thoraxjnl-2012-203123","article-title":"Early mortality after surgical resection for lung cancer: an analysis of the English National Lung Cancer Audit","volume":"68","author":"Powell H","year":"2013","unstructured":"Powell H, Tata LJ, Baldwin DR, . Early mortality after surgical resection for lung cancer: an analysis of the English National Lung Cancer Audit. Thorax 2013;68:826\u201334. https:\/\/doi.org\/10.1136\/thoraxjnl-2012\u2013203123. Medline: 23687050","journal-title":"Thorax"},{"key":"e_1_3_11_15_2","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.athoracsur.2014.06.024","article-title":"Thirty-day mortality underestimates the risk of early death after major resections for thoracic malignancies","volume":"98","author":"McMillan RR","year":"2014","unstructured":"McMillan RR, Berger A, Sima CS, . Thirty-day mortality underestimates the risk of early death after major resections for thoracic malignancies. Ann Thorac Surg. 2014;98:1769\u201375. https:\/\/doi.org\/10.1016\/j.athoracsur.2014.06.024. Medline: 25200731","journal-title":"Ann Thorac Surg"},{"key":"e_1_3_11_16_2","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.athoracsur.2010.01.069","article-title":"The 30- versus 90-day operative mortality after pulmonary resection","volume":"89","author":"Bryant AS","year":"2010","unstructured":"Bryant AS, Rudemiller K, Cerfolio RJ. The 30- versus 90-day operative mortality after pulmonary resection. Ann Thorac Surg. 2010;89:1717\u201323. https:\/\/doi.org\/10.1016\/j.athoracsur.2010.01.069. Medline: 20494017","journal-title":"Ann Thorac Surg"},{"key":"e_1_3_11_17_2","doi-asserted-by":"crossref","first-page":"e642","DOI":"10.1016\/j.cllc.2020.12.011","article-title":"Ninety-day mortality: redefining the perioperative period after lung resection","volume":"22","author":"Taylor M","year":"2021","unstructured":"Taylor M, Grant SW, West D, . Ninety-day mortality: redefining the perioperative period after lung resection. Clin Lung Cancer. 2021;22:e642\u20135. https:\/\/doi.org\/10.1016\/j.cllc.2020.12.011. Medline: 33478911","journal-title":"Clin Lung Cancer"},{"key":"e_1_3_11_18_2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.suronc.2018.07.017","article-title":"Half the deaths after surgery for lung cancer occur after discharge","volume":"27","author":"Quero-Valenzuela F","year":"2018","unstructured":"Quero-Valenzuela F, Piedra-Fern\u00e1ndez I, Hern\u00e1ndez-Escobar F, . Half the deaths after surgery for lung cancer occur after discharge. Surg Oncol. 2018;27:630\u20134. https:\/\/doi.org\/10.1016\/j.suronc.2018.07.017. Medline: 30449483","journal-title":"Surg Oncol"},{"key":"e_1_3_11_19_2","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.jtcvs.2014.07.077","article-title":"Ninety-day mortality after resection for lung cancer is nearly double 30-day mortality","volume":"148","author":"Pezzi CM","year":"2014","unstructured":"Pezzi CM, Mallin K, Mendez AS, . Ninety-day mortality after resection for lung cancer is nearly double 30-day mortality. J Thorac Cardiovasc Surg. 2014;148:2269\u201378. https:\/\/doi.org\/10.1016\/j.jtcvs.2014.07.077. Medline: 25172318","journal-title":"J Thorac Cardiovasc Surg"},{"key":"e_1_3_11_20_2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jtcvs.2019.02.123","article-title":"Challenging 30-day mortality as a site-specific quality metric in non\u2013small cell lung cancer","volume":"158","author":"Moore CB","year":"2019","unstructured":"Moore CB, Cox ML, Mulvihill MS, . Challenging 30-day mortality as a site-specific quality metric in non\u2013small cell lung cancer. J Thorac Cardiovasc Surg. 2019;158:570\u20138.e3. https:\/\/doi.org\/10.1016\/j.jtcvs.2019.02.123. Medline: 31056356","journal-title":"J Thorac Cardiovasc Surg"},{"key":"e_1_3_11_21_2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.athoracsur.2013.12.016","article-title":"Postoperative mortality is an inadequate quality indicator for lung cancer resection","volume":"97","author":"Hu Y","year":"2014","unstructured":"Hu Y, McMurry TL, Wells KM, . Postoperative mortality is an inadequate quality indicator for lung cancer resection. Ann Thorac Surg. 2014;97:973\u20139. https:\/\/doi.org\/10.1016\/j.athoracsur.2013.12.016. Medline: 24480256","journal-title":"Ann Thorac Surg"},{"key":"e_1_3_11_22_2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00000542-199901000-00008","article-title":"Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery","volume":"90","author":"Ziser A","year":"1999","unstructured":"Ziser A, Plevak DJ, Wiesner RH, . Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 1999;90:42\u201353. https:\/\/doi.org\/10.1097\/00000542\u2013199901000\u201300008. Medline: 9915311","journal-title":"Anesthesiology"},{"key":"e_1_3_11_23_2","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.athoracsur.2006.04.083","article-title":"Lung cancer surgery in patients with liver cirrhosis","volume":"82","author":"Iwasaki A","year":"2006","unstructured":"Iwasaki A, Shirakusa T, Okabayashi K, . Lung cancer surgery in patients with liver cirrhosis. Ann Thorac Surg. 2006;82:1027\u201332. https:\/\/doi.org\/10.1016\/j.athoracsur.2006.04.083. Medline: 16928529","journal-title":"Ann Thorac Surg"},{"key":"e_1_3_11_24_2","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.athoracsur.2007.07.030","article-title":"Long-term outcome of surgical treatment for non-small cell lung cancer with comorbid liver cirrhosis","volume":"84","author":"Iwata T","year":"2007","unstructured":"Iwata T, Inoue K, Nishiyama N, . Long-term outcome of surgical treatment for non-small cell lung cancer with comorbid liver cirrhosis. Ann Thorac Surg. 2007;84:1810\u20137. https:\/\/doi.org\/10.1016\/j.athoracsur.2007.07.030. Medline: 18036890","journal-title":"Ann Thorac Surg"},{"key":"e_1_3_11_25_2","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1510\/icvts.2007.162487","article-title":"Factors predicting early postoperative liver cirrhosis-related complications after lung cancer surgery in patients with liver cirrhosis","volume":"6","author":"Iwata T","year":"2007","unstructured":"Iwata T, Inoue K, Nishiyama N, . Factors predicting early postoperative liver cirrhosis-related complications after lung cancer surgery in patients with liver cirrhosis. Interact Cardiovasc Thorac Surg. 2007b;6:720\u201330. https:\/\/doi.org\/10.1510\/icvts.2007.162487. Medline: 17766277","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"e_1_3_11_26_2","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/ejcts\/ezx190","article-title":"Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78 594 patients during 2014\u20132015","volume":"52","author":"Endo S","year":"2017","unstructured":"Endo S, Ikeda N, Kondo T, . Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78 594 patients during 2014\u20132015. Eur J Cardiothorac Surg. 2017;52:1182\u20139. https:\/\/doi.org\/10.1093\/ejcts\/ezx190. Medline: 28977408","journal-title":"Eur J Cardiothorac Surg"},{"key":"e_1_3_11_27_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pneumo.2014.09.006","article-title":"Chirurgie du cancer du poumon chez le cirrhotique [Lung cancer surgery and cirrhosis]","volume":"71","author":"Rivera C","year":"2015","unstructured":"Rivera C, Chevalier B, Fabre E, . Chirurgie du cancer du poumon chez le cirrhotique [Lung cancer surgery and cirrhosis]. Rev Pneumol Clin. 2015;71(1):12\u20139. https:\/\/doi.org\/10.1016\/j.pneumo.2014.09.006. Medline: 25687820","journal-title":"Rev Pneumol Clin"},{"key":"e_1_3_11_28_2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/hed.21486","article-title":"Predicting postoperative morbidity and mortality by model for endstage liver disease score for patients with head and neck cancer and liver cirrhosis","volume":"33","author":"Kao H","year":"2011","unstructured":"Kao H, Guo L, Cheng M, . Predicting postoperative morbidity and mortality by model for endstage liver disease score for patients with head and neck cancer and liver cirrhosis. Head Neck 2011;33:529\u201334. https:\/\/doi.org\/10.1002\/hed.21486. Medline: 20665744","journal-title":"Head Neck"},{"key":"e_1_3_11_29_2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.amjsurg.2020.01.022","article-title":"The impact of cirrhosis and MELD score on postoperative morbidity and mortality among patients selected for liver resection","volume":"220","author":"Zaydfudim VM","year":"2020","unstructured":"Zaydfudim VM, Turrentine FE, Smolkin ME, . The impact of cirrhosis and MELD score on postoperative morbidity and mortality among patients selected for liver resection. Am J Surg. 2020;220:682\u20136. https:\/\/doi.org\/10.1016\/j.amjsurg.2020.01.022. Medline: 31983407","journal-title":"Am J Surg"},{"key":"e_1_3_11_30_2","first-page":"192","article-title":"Surgery in the patient with liver disease","volume":"121","author":"Friedman LS","year":"2010","unstructured":"Friedman LS. Surgery in the patient with liver disease. Trans Am Clin Climatol Assoc. 2010;121:192\u2013204. Medline: 20697561","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"e_1_3_11_31_2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/jso.23856","article-title":"The short- and long-term outcomes of pancreaticoduodenectomy for cancer in Child A patients are acceptable: a patient-control study from the Surgical French Association report for pancreatic surgery","volume":"111","author":"Regimbeau J","year":"2015","unstructured":"Regimbeau J, Rebibo L, Dokmak S, . The short- and long-term outcomes of pancreaticoduodenectomy for cancer in Child A patients are acceptable: a patient-control study from the Surgical French Association report for pancreatic surgery. J Surg Oncol. 2015;111:776\u201383. https:\/\/doi.org\/10.1002\/jso.23856. Medline: 25663324","journal-title":"J Surg Oncol"},{"key":"e_1_3_11_32_2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10620-007-9884-3","article-title":"Clinical outcomes of patients with liver cirrhosis who underwent curative surgery for gastric cancer: a retrospective multi-center study","volume":"53","author":"Jang HJ","year":"2007","unstructured":"Jang HJ, Kim JH, Song HH, . Clinical outcomes of patients with liver cirrhosis who underwent curative surgery for gastric cancer: a retrospective multi-center study. Dig Dis Sc. 2007;53:399\u2013404. https:\/\/doi.org\/10.1007\/s10620\u2013007\u20139884\u20133. Medline: 17597403","journal-title":"Dig Dis Sc"},{"key":"e_1_3_11_33_2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cgh.2011.12.030","article-title":"Safety of cardiac surgery for patients with cirrhosis and Child\u2013Pugh scores less than 8","volume":"10","author":"Macaron C","year":"2012","unstructured":"Macaron C, Hanouneh IA, Suman A, . Safety of cardiac surgery for patients with cirrhosis and Child\u2013Pugh scores less than 8. Clin Gastroenterol Hepat. 2012;10:535\u20139. https:\/\/doi.org\/10.1016\/j.cgh.2011.12.030. Medline: 22210437","journal-title":"Clin Gastroenterol Hepat"},{"key":"e_1_3_11_34_2","doi-asserted-by":"crossref","first-page":"12608","DOI":"10.3748\/wjg.v20.i35.12608","article-title":"Cardiac surgery in patients with liver cirrhosis: risk factors for predicting mortality","volume":"20","author":"Lin CH","year":"2014","unstructured":"Lin CH, Hsu RB. Cardiac surgery in patients with liver cirrhosis: risk factors for predicting mortality. World J Gastroenterol. 2014;20:12608. https:\/\/doi.org\/10.3748\/wjg.v20.i35.12608. Medline: 25253965","journal-title":"World J Gastroenterol"},{"key":"e_1_3_11_35_2","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.athoracsur.2020.06.110","article-title":"Cardiac surgery in patients with liver cirrhosis (CASTER) study: early and long-term outcomes","volume":"111","author":"Garatti A","year":"2021","unstructured":"Garatti A, Daprati A, Cottini M, . Cardiac surgery in patients with liver cirrhosis (CASTER) study: early and long-term outcomes. Ann Thorac Surg. 2021;111:1242\u201351. https:\/\/doi.org\/10.1016\/j.athoracsur.2020.06.110. Medline: 32919974","journal-title":"Ann Thorac Surg"},{"key":"e_1_3_11_36_2","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S1072-7515(03)00117-0","article-title":"Colorectal adenocarcinoma in cirrhotic patients","volume":"196","author":"Gervaz P","year":"2003","unstructured":"Gervaz P, Pak-Art R, Nivatvongs S, . Colorectal adenocarcinoma in cirrhotic patients. J Am Coll Surg. 2003;196:874\u20139. https:\/\/doi.org\/10.1016\/S1072\u20137515(03)00117\u20130. Medline: 12788423","journal-title":"J Am Coll Surg"},{"key":"e_1_3_11_37_2","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.amjsurg.2020.02.035","article-title":"The impact of cirrhosis on esophageal cancer surgery: an up-to-date meta-analysis","volume":"220","author":"Schizas D S","year":"2020","unstructured":"Schizas D S, Vailas M. The impact of cirrhosis on esophageal cancer surgery: an up-to-date meta-analysis. Am J Sur. 2020;220:865\u201372. https:\/\/doi.org\/10.1016\/j.amjsurg.2020.02.035. Medline: 32107011","journal-title":"Am J Sur"},{"key":"e_1_3_11_38_2","first-page":"43","article-title":"Survival of patients with lung cancer in the setting of liver cirrhosis: a multicenter propensity score matching study","volume":"13","author":"Lu MS","year":"2021","unstructured":"Lu MS, Lu HI, Chen TP, . Survival of patients with lung cancer in the setting of liver cirrhosis: a multicenter propensity score matching study. Cancer Manage Res. 2021;13:43\u201381. https:\/\/doi.org\/10.2147\/CMAR.S304980. Medline: 34103992","journal-title":"Cancer Manage Res"},{"key":"e_1_3_11_39_2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/flgastro-2023-102381","article-title":"Guidance document: risk assessment of patients with cirrhosis prior to elective non-hepatic surgery","volume":"14","author":"Abbas N","unstructured":"Abbas N, Fallowfield J, Patch D, . Guidance document: risk assessment of patients with cirrhosis prior to elective non-hepatic surgery. Frontline Gastroenterol. 2923b;14:359\u201370. https:\/\/doi.org\/10.1136\/flgastro-2023\u2013102381. Medline: 37581186","journal-title":"Frontline Gastroenterol"},{"key":"e_1_3_11_40_2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jhep.2008.03.009","article-title":"Thrombocytopaenia associated with chronic liver disease","volume":"48","author":"Afdhal N","year":"2008","unstructured":"Afdhal N, McHutchison J, Brown R, . Thrombocytopaenia associated with chronic liver disease. J Hepatol. 2008;48:1000\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2008.03.009. Medline: 18433919","journal-title":"J Hepatol"},{"key":"e_1_3_11_41_2","first-page":"1910","article-title":"Real-world, population-based cohort study of toxicity and resource utilization of second-line ipilimumab for metastatic melanoma in Ontario, Canada","volume":"148","author":"Dai WF","year":"2020","unstructured":"Dai WF, Beca J, Croxford R, . Real-world, population-based cohort study of toxicity and resource utilization of second-line ipilimumab for metastatic melanoma in Ontario, Canada. Int J Cancer. 2020;148:1910\u20138. https:\/\/doi.org\/10.1002\/ijc.33357. Medline: 33105030","journal-title":"Int J Cancer"}],"container-title":["Canadian Liver Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/canlivj-2025-0055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:41:07Z","timestamp":1786977667000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/canlivj-2025-0055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8,1]]}},"alternative-id":["10.3138\/canlivj-2025-0055"],"URL":"https:\/\/doi.org\/10.3138\/canlivj-2025-0055","relation":{},"ISSN":["2561-4444"],"issn-type":[{"value":"2561-4444","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}